Disarticulation

The Titan disaster investigation has begun. An expert explains what might happen next

Retrieved on: 
Martedì, Giugno 27, 2023
Aircraft, US Coast Guard and Geodetic Survey Seismological and Geomagnetic House, Disarticulation, Travel, Missions of the United States Coast Guard, International Convention on Maritime Search and Rescue, United Nations Convention on the Law of the Sea, United Nations Convention, Hope, Research, Sea, CNN, Radar, United States Coast Guard, Animal, Seawater, Fracture, Water, Joint, Kenya Coast Guard Service, United Kingdom, Observation, Weather, Private law, International law, ROV, Titanic, Safety, Dredging, Demolition, Private investigator, Uranium mining, Rare-earth element, Surveying, Titan

The vessel experienced a catastrophic implosion at some point during its journey, with all five passengers presumed dead.

Key Points: 
  • The vessel experienced a catastrophic implosion at some point during its journey, with all five passengers presumed dead.
  • An expert explains

    For now, details elude us – and it could be days, or even weeks, before we receive meaningful updates on the investigation’s progress.

  • The Titan disaster happened in international waters, in a commercially operated vessel, and with victims of different nationalities.

What happens next?


    The Titan, a research and exploration sub owned by US company OceanGate, lost contact with its surface vessel on Sunday morning, about one hour and 45 minutes after its departure. Chief investigator Jason Neubauer said the US Coast Guard will receive help from Canada, France and the United Kingdom. He said authorities had already mapped the accident site, and the inquiry will aim to address several questions, including:
    Recovery operations in remote parts of the ocean are painstakingly complex, with myriad variables to consider. We can expect the Titan investigation will cost millions of dollars.

Harsh conditions

    • Manufacturer Pelagic Research Services told CNN the ROV’s lifting capabilities had “been utilised and continue to be utilised”, and that missions would continue for about a week.
    • ROVs can collect vast amounts of data for deep-sea operations, including video footage and sensor readings.
    • They may have disintegrated during the implosion, drifted too far away from the search area, or be obscured by other debris.
    • Underwater hazards, harsh weather and strong currents all add to the challenge – especially by limiting visibility.

Finding the remains

    • But the chances of actually finding them will depend on various factors, including the cause of the implosion, the depth at which it happened, and the surrounding conditions.
    • A severe implosion may have resulted in extensive fragmentation and scattering of both the submersible’s structure and human remains.
    • The effort to locate remains may involve observation from long-range aircraft and patrol vessels, or may even rely on radar, sonar or satellite imagery.

Sharing responsibility

    • The Titan investigation will involve coordination between multiple entities, including maritime authorities, coast guard services and search and rescue organisations.
    • This requires that all vessels, regardless of their flag, have a legal obligation to render assistance to any person in distress at sea.

The Titan sub disaster investigation has begun. Here’s what might happen next

Retrieved on: 
Martedì, Giugno 27, 2023
Aircraft, US Coast Guard and Geodetic Survey Seismological and Geomagnetic House, Disarticulation, Travel, Missions of the United States Coast Guard, International Convention on Maritime Search and Rescue, United Nations Convention on the Law of the Sea, United Nations Convention, Hope, Research, Sea, CNN, Radar, United States Coast Guard, Animal, Seawater, Fracture, Water, Joint, Kenya Coast Guard Service, United Kingdom, Observation, Weather, Private law, International law, ROV, Titanic, Safety, Dredging, Demolition, Private investigator, Uranium mining, Rare-earth element, Surveying, Titan

The United States Coast Guard is now leading the investigation into the Titan submersible, looking for answers about why it imploded, and what actions should be taken next.

Key Points: 
  • The United States Coast Guard is now leading the investigation into the Titan submersible, looking for answers about why it imploded, and what actions should be taken next.
  • The vessel experienced a catastrophic implosion at some point during its journey, with all five passengers presumed dead.
  • The Titan disaster happened in international waters, in a commercially operated vessel, and with victims of different nationalities.

What happens next?


    The Titan, a research and exploration sub owned by US company OceanGate, lost contact with its surface vessel on Sunday morning, about one hour and 45 minutes after its departure. Chief investigator Jason Neubauer said the US Coast Guard will receive help from Canada, France and the United Kingdom. He said authorities had already mapped the accident site, and the inquiry will aim to address several questions, including:
    Recovery operations in remote parts of the ocean are painstakingly complex, with myriad variables to consider. We can expect the Titan investigation will cost millions of dollars.

Harsh conditions

    • Manufacturer Pelagic Research Services told CNN the ROV’s lifting capabilities had “been utilised and continue to be utilised”, and that missions would continue for about a week.
    • ROVs can collect vast amounts of data for deep-sea operations, including video footage and sensor readings.
    • They may have disintegrated during the implosion, drifted too far away from the search area, or be obscured by other debris.
    • Underwater hazards, harsh weather and strong currents all add to the challenge – especially by limiting visibility.

Finding the remains

    • But the chances of actually finding them will depend on various factors, including the cause of the implosion, the depth at which it happened, and the surrounding conditions.
    • A severe implosion may have resulted in extensive fragmentation and scattering of both the submersible’s structure and human remains.
    • The effort to locate remains may involve observation from long-range aircraft and patrol vessels, or may even rely on radar, sonar or satellite imagery.

Sharing responsibility

    • The Titan investigation will involve coordination between multiple entities, including maritime authorities, coast guard services and search and rescue organisations.
    • This requires that all vessels, regardless of their flag, have a legal obligation to render assistance to any person in distress at sea.

Centinel Spine® Announces First Commercial Use of prodisc® C SK Cervical Total Disc Replacement Product

Retrieved on: 
Giovedì, Novembre 10, 2022
WEST, Food, Anatomy, Technology, Spine, SK, Solution, Culture, Food and Drug Administration, Company, TDR, Surgeon, CORE, Disarticulation, Industry, MD, FDA, LLC, Bookbinding, Medical device

prodisc C SK expands availability of Centinel Spine's portfolio of FDA-approved cervical total disc replacement (TDR) devices.

Key Points: 
  • prodisc C SK expands availability of Centinel Spine's portfolio of FDA-approved cervical total disc replacement (TDR) devices.
  • Centinel Spine now has three cervical TDR devices available in the U.S. for 1-level indications: prodisc C, prodisc C Vivo, and prodisc C SK.
  • WEST CHESTER, Pa., Nov. 10, 2022 /PRNewswire/ -- Centinel Spine, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the first implantation of its prodisc C SK Cervical Total Disc Replacement (TDR) product.
  • In July, the Company received U.S. Food and Drug Administration approval for 1-level indications for prodisc C Vivo, prodisc C SK, and prodisc C Nova.

Centinel Spine Announces 100th Procedure with prodisc® C Vivo Cervical Total Disc Replacement Product

Retrieved on: 
Giovedì, Ottobre 27, 2022
LLC, Degenerative disc disease, Disarticulation, Pain, Spine, Solution, Surgeon, Industry, Technology, WEST, Culture, Patient, Company, TDR, Anatomy, Disability, X-ray, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Vivo, CORE, Motion, Medical device, Birth control, Dentistry

The 100th procedure milestone was achieved quickly following the announcement of the first U.S. prodisc C Vivo implantation on Sept. 7.

Key Points: 
  • The 100th procedure milestone was achieved quickly following the announcement of the first U.S. prodisc C Vivo implantation on Sept. 7.
  • The prodisc C Vivo device incorporates prodisc CORE technology used in over 225,000 implantations worldwide.
  • WEST CHESTER, Pa., Oct. 27, 2022 /PRNewswire/ --Centinel Spine, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the 100th completed procedure in the United States with its prodisc C Vivo Cervical Total Disc Replacement (TDR) product.
  • This milestone was achieved quickly after the Company announced the first U.S. implantation of the prodisc C Vivo on Sept. 7.

Centinel Spine Wins Third Consecutive Spine Technology Award for prodisc® Cervical Portfolio & Match-the-Disc Platform

Retrieved on: 
Mercoledì, Ottobre 19, 2022
Physician, Culture, Anatomy, LLC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, WEST, Hospital, Research, Surgeon, Program, NASS, Annual general meeting, Orthopedic surgery, Technology, North American Spine Society, Spine, Food, CORE, Company, Food and Drug Administration, Industry, Motion, Disarticulation, Invention, TDR, FDA, Solution, Medical device, Bookbinding, Birth control, Medicine, PubMed, Embase

This is the third consecutive year that the Company has won a Spine Technology Award.

Key Points: 
  • This is the third consecutive year that the Company has won a Spine Technology Award.
  • Centinel Spine accepted the award at the North American Spine Society (NASS) 37th Annual Meeting, held from October 12-15 in Chicago, Illinois.
  • All prodisc products incorporate prodisc CORE technology, the basis behind the predictable clinical outcomes of every prodisc device in over 225,000 implantations worldwide.
  • Centinel Spine remains the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.

Centinel Spine® Continues Launch of New Portfolio of prodisc® Cervical Total Disc Replacement Devices & Features at NASS 2022

Retrieved on: 
Martedì, Ottobre 4, 2022
Solution, NASS, CORE, Samuel Bryan, Annual general meeting, Culture, Technology, Industry, Food, FDA, TDR, Anatomy, Food and Drug Administration, Pathology, North American Spine Society, LLC, WEST, Disarticulation, Spine, Surgeon, Bookbinding, Medical device

Centinel Spine now has four FDA-approved cervical total disc replacement devices for 1-level indications, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.

Key Points: 
  • Centinel Spine now has four FDA-approved cervical total disc replacement devices for 1-level indications, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.
  • WEST CHESTER, Pa., Oct. 4, 2022 /PRNewswire/ -- Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced continued expansion of the availability of the prodisc Cervical Total Disc Replacement (TDR) portfolio that allows the disc to be matched to patient anatomy.
  • In July, the company received U.S. Food and Drug Administration approval for 1-level indications for prodisc C Vivo, prodisc C SK, and prodisc C Nova.
  • The new prodisc portfolio of cervical and lumbar TDR products will be featured at the Centinel Spine booth #4224, as well as multiple podium presentations during NASS 2022.

Centinel Spine® Announces First Commercial Use of prodisc® Cervical Total Disc Replacement Portfolio that Allows the Disc to be Matched to Patient Anatomy

Retrieved on: 
Mercoledì, Settembre 7, 2022
Technology, Spine, Food and Drug Administration, Thumb, Solution, Disarticulation, Forearm, WEST, Culture, Subsidence, Food, Anatomy, MD, Implant failure, Surgeon, Leadership, FDA, National Center for Spinal Disorders, LLC, Elective surgery, Risk, Motion, Samuel Bryan, Heterotopic ossification, Industry, CORE, TDR, Health, Medical device, Bookbinding

Centinel Spine now has four FDA-approved cervical total disc replacement (TDR) devices for 1-level indications, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.

Key Points: 
  • Centinel Spine now has four FDA-approved cervical total disc replacement (TDR) devices for 1-level indications, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.
  • Centinel Spine continues its leadership in total disc replacement, becoming the first-and-only company with a portfolio that allows matching the disc to patient anatomy.
  • In July, the company received U.S. Food and Drug Administration approval for 1-level indications for prodisc C Vivo, prodisc C SK, and prodisc C Nova.
  • Centinel Spine remains the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.

Centinel Spine® Expands Its Comprehensive Cervical Solutions Portfolio With Full Commercial Launch of FORTOS-C™ Anterior Cervical Plating System

Retrieved on: 
Martedì, Luglio 26, 2022
CA, Motion, PEEK, Disarticulation, Lordosis, Industry, CEO, Culture, FLX, Solution, 3D, Spine, Golden, WEST, Technology, LLC, Injection moulding, Bookbinding, Birth control

WEST CHESTER, Pa., July 26, 2022 /PRNewswire/ -- Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the full commercial launch of the FORTOS-C Anterior Cervical Plating System.

Key Points: 
  • WEST CHESTER, Pa., July 26, 2022 /PRNewswire/ -- Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the full commercial launch of the FORTOS-C Anterior Cervical Plating System.
  • With this introduction, Centinel Spine expands its cervical portfolio and further solidifies its leadership position as one of the few companies to offer a comprehensive line of cervical fusion and motion preservation solutions.
  • FORTOS-Cnow joins Centinel Spine's comprehensive portfolio of cervical solutions, including the ACTILIF C interbody system, STALIF C Integrated Interbody system, ALTOS PCT posterior cervical system, and prodisc C Cervical Total Disc Replacement system.
  • Centinel Spine remains the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.

Centinel Spine® Receives FDA Approval for 3 Additional prodisc® Cervical Total Disc Replacement Devices

Retrieved on: 
Mercoledì, Luglio 13, 2022
Technology, Culture, Surgeon, Intervertebral disc arthroplasty, Nova, LLC, Samuel Bryan, Solution, PMA, CEO, Spine, SK, MD, Food, TDR, Competitive landscape, Disarticulation, CORE, WEST, CAGR, FDA, National Center for Spinal Disorders, Food and Drug Administration, Growth, Industry, Anatomy, Medical imaging, Birth control, Medical device

Centinel Spine now has four PMA approved cervical Total Disc Replacement (TDR) devices, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.

Key Points: 
  • Centinel Spine now has four PMA approved cervical Total Disc Replacement (TDR) devices, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy.
  • WEST CHESTER, Pa., July 13, 2022 /PRNewswire/ --Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced U.S. Food and Drug Administration (FDA) Pre-Market Application (PMA) Approval for 1-level indications for three additional cervical total disc replacement (TDR) devices: prodisc C Vivo, prodisc C Nova, and prodisc C SK.
  • Centinel Spine also continues to enroll for a two-level prospective, randomized, multi-centered clinical study evaluating prodisc C Vivo and prodisc C SK.
  • Centinel Spine remains the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.

Major Commercial Third Party Payer in Utah and Idaho Significantly Expands Patient Access to Centinel Spine's prodisc® L for One- and Two-level Lumbar Total Disc Replacement

Retrieved on: 
Martedì, Aprile 5, 2022
Culture, DDD, Publication, TDR, CEO, WEST, LLC, Industry, Annual general meeting, North American Spine Society, NASS, Surgeon, Disarticulation, Policy, Spine, FDA, Patient, Health insurance, Medical device, Bookbinding

WEST CHESTER, Pa., April 5, 2022 /PRNewswire/ -- Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced significant expansion of coverage for lumbar total disc replacement (TDR) procedures in Utah and Idaho. This policy expansion announced by a major commercial third party payer represents 837,000 covered lives across the two states and includes a positive coverage recommendation for both one- and two-level lumbar TDR. The policy specifically references coverage with Centinel Spine's prodisc® L system, the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.

Key Points: 
  • - Centinel Spine continues to advance lumbar motion preservation, through a recent two-level FDA approval and launch of Angled Anatomic Endplate implants.
  • - Centinel Spine's prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
  • The policy specifically references coverage with Centinel Spine's prodisc L system, the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
  • The commercial third party payer, the largest operating in Utah and the third largest operating in Idaho, previously had no coverage policy for either one- or two-level lumbar disc replacement.